SA
SRN Advisors’s West Pharmaceutical WST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-3,323
| Closed | -$1.25M | – | 115 |
|
2023
Q3 | $1.25M | Buy |
3,323
+64
| +2% | +$24K | 1.24% | 28 |
|
2023
Q2 | $1.25M | Sell |
3,259
-98
| -3% | -$37.5K | 1.11% | 35 |
|
2023
Q1 | $1.14M | Buy |
3,357
+579
| +21% | +$197K | 1.05% | 43 |
|
2022
Q4 | $654K | Buy |
2,778
+360
| +15% | +$84.7K | 0.65% | 79 |
|
2022
Q3 | $595K | Sell |
2,418
-513
| -18% | -$126K | 0.5% | 95 |
|
2022
Q2 | $886K | Sell |
2,931
-482
| -14% | -$146K | 0.62% | 73 |
|
2022
Q1 | $1.4M | Buy |
3,413
+32
| +0.9% | +$13.1K | 0.62% | 54 |
|
2021
Q4 | $1.59M | Buy |
3,381
+250
| +8% | +$117K | 0.57% | 48 |
|
2021
Q3 | $1.33M | Sell |
3,131
-2,312
| -42% | -$982K | 0.62% | 43 |
|
2021
Q2 | $1.95M | Sell |
5,443
-330
| -6% | -$119K | 0.67% | 50 |
|
2021
Q1 | $1.63M | Sell |
5,773
-1,107
| -16% | -$312K | 0.58% | 62 |
|
2020
Q4 | $1.93M | Buy |
+6,880
| New | +$1.93M | 0.95% | 47 |
|